The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development of a machine learning model to predict overall survival results from randomized clinical trials of patients with metastatic prostate cancer.
 
Ali Sabbagh
No Relationships to Disclose
 
David Alan Quigley
No Relationships to Disclose
 
Nicholas Lillis
No Relationships to Disclose
 
Li Zhang
No Relationships to Disclose
 
Isabel D Friesner
No Relationships to Disclose
 
Adina Bailey
No Relationships to Disclose
 
Rahul Raj Aggarwal
Consulting or Advisory Role - Alessa Therapeutics; Amgen; AstraZeneca; Bayer; BioXcel Therapeutics; Boxer Capital; EcoR1 Capital; Exelixis; Janssen; Jubilant Pharmaceuticals; Merck; Novartis; OncLive.; PCCTC; Pfizer; Tersera
Research Funding - Amgen (Inst); AstraZeneca (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Xynomic Pharma (Inst); Zenith Epigenetics (Inst)
Expert Testimony - University of Utah Health
Travel, Accommodations, Expenses - DAVA Oncology
 
Meera Reddy Chappidi
Employment - Horizon Therapeutics (I)
Stock and Other Ownership Interests - Horizon Therapeutics (I)
 
Hari Singhal
Stock and Other Ownership Interests - JJ Innovative Medicine
 
Ke Zhang
Employment - JJ Innovative Medicine
Stock and Other Ownership Interests - JJ Innovative Medicine
Research Funding - JJ Innovative Medicine
 
Joel Greshock
Employment - Johnson & Johnson/Janssen
 
Jinhui Li
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Margaret K. Yu
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
Patents, Royalties, Other Intellectual Property - Invention patent for invention of apalutamide for the treatment of patients with non-metastatic castration resistant prostate cancer
Travel, Accommodations, Expenses - J&J IM
 
Eric J. Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics; Teon Therapeutics
Honoraria - Janssen
Consulting or Advisory Role - Fortis; Janssen Oncology; Teon Therapeutics
 
Julian C. Hong
Research Funding - Roche (Inst)